US Patent Issued to FIVE PRIME THERAPEUTICS on June 23 for "Pharmaceutical formulations containing CD80 extracellular domain-Fc fusion proteins" (California Inventor)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,523, issued on June 23, was assigned to FIVE PRIME THERAPEUTICS INC. (Thousand Oaks, Calif.).

"Pharmaceutical formulations containing CD80 extracellular domain-Fc fusion proteins" was invented by Yong Quan (Dublin, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides pharmaceutical compositions comprising CD80 extracellular domain (ECD)-fragment crystallizable (Fc) fusion molecules. The present disclosure also provides methods for treating solid tumors by administering such pharmaceutical compositions."

The patent was filed on May 1, 2020, under Application No. 17/608,546.

*For further information, including images...